K

Kensei Yamaguchi

Japanese Foundation For Cancer Research

ORCID: 0000-0001-6887-5709

Publishes on Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers. 924 papers and 22.7k citations.

PubIndex Score98Top 2%How it's scored

924Publications

22.7kTotal Citations

First publication: 1971First senior author: 1977

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Cancer Treatment and Pharmacology

Top publicationsby citations

Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

Salvatore Siena, Takayuki Yoshino, Maria Di Bartolomeo et al.|The Lancet Oncology|2021

Cited by 411

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies

Yoshiaki Nakamura, Takayuki Yoshino, Takeshi Kato et al.|Nature Medicine|2020

Cited by 366

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav et al.|Nature Communications|2023

Cited by 159

Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912)

Narikazu Boku, Atsushi Ohtsu, Suguru Yamamoto et al.|Journal of Clinical Oncology|2007

Cited by 158

Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

Kanwal Raghav, Takayuki Yoshino, Salvatore Siena et al.|The Lancet Oncology|2024

Cited by 124